About us

NBTC was established in 2021 supported by a basic grant funding from the Norwegian Cancer Society through the funding initiative Krafttak mot kreft. NBTC has also received financial support from the Norwegian Brain Tumor Association. The prerequisite for the establishment of NBTC was that leading Norwegian researchers and clinicians work together, in collaboration towards achieving key common goals, where research data, knowledge and expertise are shared. This approach will enable an increased level of collaboration on clinical studies both at a national and international level with the aim to offer new and experimental treatment to brain tumor patients.

The Consortium

Out Partners

Members

Prof. Rolf Bjerkvig

Nina Jensen

Dr. Terje Sundstrøm

Liv Marit Dørum

Fagansvarlig for kvalitetsregistrene, Kreftregisteret

liv.marit.dorum@kreftregisteret.no

Dr. Tor Ingebrigtsen

Dr. Iver A Langmoen

Dr. Petter Brandal

Dr. Einar Vik-Mo

Prof. Magnar Bjørås

Dr. Ole Solheim

Prof. Frits Thorsen

Prof. Hrvoje Miletic

Dr. Tor-Christian Johannessen

Dr. Fredrik Sund

Board of directors in the consortium

The board of directors in the consortium consist of two members from each institution.

Dr. Fredrik Sund

Dr. Tor Ingebrigtsen

Prof. Magnar Bjørås

Dr. Iver A Langmoen

Dr. Ole Solheim

Dr. Terje Sundstrøm

Nina Jensen

Dr. Einar Vik-Mo

Prof. Rolf Bjerkvig

Tom B. Johannesen

Kreftregisteret

tom.johannesen@kreftregisteret.no